Ingevity Corp

Ingevity Corp

NGVT - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$2.08B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Ingevity CorpIngevity Corp34.7-95%1.918.7
$16.65

Current Fair Value

73% downside

Overvalued by 73% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$2.08 Billion
Enterprise Value$3.18 Billion
Earnings per Share$-4.61
Beta1.12
Outstanding Shares34,300,000

Return

Return on Equity94.92%ROE
Return on Assets3.98%
Return on Invested Capital10.32%

Valuation & Multiples

P/E Ratio34.67P/E Ratio
PEG260.06PEG
Price to Sales1.87Price to Sales
Price to Book Ratio61.7Price to Book Ratio
Enterprise Value to Revenue2.81
Enterprise Value to EBIT26.91
Enterprise Value to Net Income53
Total Debt to Enterprise0.37
Debt to Equity18.71Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
November 4, 2026
EPS
$1.63
Est. $1.56
Revenue
$305.10 M
Est. $303.91 M

Next Earnings Call

Expected Date
February 24, 2027
EPS Estimate
$0.88
Consensus analyst estimate
Revenue Estimate
$231.90 M
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.00000%
Total Calls-
Total Puts-

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %13.32%▼ 88.80%
Total Invested$329.76M▼ 87.62%
Investors Holding152▼ 164.00%

About Ingevity Corp

CEO: Richard Kelson

Ingevity provides specialty chemicals, high-performance carbon materials and engineered polymers that purify, protect and enhance the world around us. Through a team of talented and experienced people, Ingevity develops, manufactures, an...

Ingevity Insider Information FAQ

Stockcircle tracks 9 top investors with a current 13F position in Ingevity. Notable holders include Bridgewater Associates. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 1 top investor increased or opened positions and 2 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 7 open-market insider sales for Ingevity in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.